INS and Hyperglycemia: Enhanced insulin secretion of β cells, accelerated normalization of hyperglycemia with glycemic correction lasting >150 days. Limited infiltration of effector T cells, macrophages and increased recruitment of Foxp3+ regulatory T cells to the islet grafts.